Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion

Patients with lower-grade gliomas (LGGs) have highly diverse clinical outcomes. Although histological features and molecular markers have been used to predict prognosis, the identification of new biomarkers for the accurate prediction of patient outcomes is still needed. The serine synthesis pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shang-Pen, Chan, Yung-Chieh, Huang, Shang-Yu, Lin, Yuan-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016949/
https://www.ncbi.nlm.nih.gov/pubmed/31861486
http://dx.doi.org/10.3390/cancers12010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016949/
https://www.ncbi.nlm.nih.gov/pubmed/31861486
http://dx.doi.org/10.3390/cancers12010013

Ejemplares similares